Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 60/100

Kymera Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27

Thursday, February 20, 2025 1 min read
Key Takeaway: Kymera Therapeutics is set to report its fourth quarter and full year 2024 financial results on February 27, 2025. The company, known for its innovative oral small molecule degrader medicines, will hold a video conference call at 8:30 a.m. ET to discuss these results. The event will allow investors and stakeholders to gain insights into the company's performance and future prospects.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics will provide insights into its financial performance for 2024.
  • The introduction of a new video conference call format allows for broader accessibility.
  • The company focuses on innovative therapies for immunological diseases.

Full Press Release Details

WATERTOWN, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines with biologics-like activity for immunological diseases, will report fourth quarter and full year 2024 financial results on February 27, 2025. The Company will host a new video conference call format at 8:30 a.m. ET that day.
To join the video call or view the livestreamed webcast, please register via this link, or visit “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.
About Kymera Therapeutics
Investor and Media Contact:
Vice President, Investor Relations
investors@kymeratx.com

Tags

Targeted Protein Degradation

Frequently Asked Questions

When will Kymera report its financial results for 2024?

Kymera will report its fourth quarter and full year 2024 financial results on February 27, 2025.

What time is the video conference call on February 27?

The video conference call will take place at 8:30 a.m. ET on February 27.

How can I join the Kymera video call?

To join the video call, register via the provided link or visit the company's website.

Will there be a replay of the webcast?

Yes, a replay of the webcast will be archived and available after the event.

What is Kymera Therapeutics focused on?

Kymera Therapeutics focuses on a new class of oral small molecule degrader medicines.

Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics immunological diseases financial results biopharmaceuticals
Last updated: Feb 20, 2025